Karlo M Pedro - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Global Spine Journal|April 21, 2025

AO Spine Clinical Practice Recommendations for Diagnosis and Management of Degenerative Cervical Myelopathy: Evidence Based Decision Making - A Review of Cutting Edge Recent Literature Related to Degenerative Cervical MyelopathyMichael G Fehlings, Nathan Evaniew, Paula Valerie Ter Wengel, et al.

JAMA Network Open|June 21, 2024

Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT TrialMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.

Ebiomedicine|July 25, 2025

The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Global Spine Journal|April 21, 2025

AO Spine Clinical Practice Recommendations for Diagnosis and Management of Degenerative Cervical Myelopathy: Evidence Based Decision Making - A Review of Cutting Edge Recent Literature Related to Degenerative Cervical MyelopathyMichael G Fehlings, Nathan Evaniew, Paula Valerie Ter Wengel, et al.

JAMA Network Open|June 21, 2024

Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT TrialMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.

Ebiomedicine|July 25, 2025

The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.

Pageof 3